Search results
Results from the WOW.Com Content Network
The Harvard School of Public Health and Dana-Farber/Harvard Cancer Center have created a Cancer FactFinder website, which is available in 9 languages.
In 2014, Freeman received the William B. Coley Award along with Tasuku Honjo, Lieping Chen and Arlene Sharpe. [3]In 2017, Freeman was one of the winners of the Warren Alpert Foundation Prize, and in 2022 he was elected to the American Academy of Arts and Sciences and the National Academy of Sciences.
He is currently Professor of Medicine at Harvard Medical School, Chair of Medical Oncology at Dana–Farber Cancer Institute, and Director of Medical Oncology at Brigham and Women's Hospital. [1] [2] He is considered an expert in medical oncology and is widely recognized for his research in the clinical and biologic aspects of hemotologic ...
Subsequently she trained at the University of California, San Francisco and Dana–Farber Cancer Institute. In 2007, she received a masters in public health from Harvard University . [ 1 ] [ 2 ] As of 2021, Ng is a physician at the Dana–Farber Cancer Institute and a professor at Harvard Medical School . [ 3 ]
Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School. As of 2023, Dana-Farber is ranked the #4 cancer hospital in the world. [1]
Alan D. D'Andrea is an American cancer researcher and the Fuller American Cancer Society Professor of Radiation Oncology at Harvard Medical School. D'Andrea's research at the Dana Farber Cancer Institute focuses on chromosome instability and cancer susceptibility. He is currently the director of the Center for DNA Damage and Repair and the ...
In 2008, the Dana-Farber Cancer Institute in Boston reported two-year overall survival of 53% and event-free survival of 70% (median age at diagnosis of 26 months). [7] In 2013, the Medical University of Vienna reported five-year overall survival of 100%, and event-free survival of 89% (median age at diagnosis of 24 months).
Benjamin Levine Ebert is the Chair of Medical Oncology at the Dana–Farber Cancer Institute and the George P. Canellos, MD and Jean S. Canellos Professor of Medicine at Harvard Medical School. Ebert has been the president and CEO of Dana-Farber since October 2024, succeeding Laurie Glimcher. [1]